Pathophysiology of Diabetic Nephropathy: Involvement of Multifaceted Signalling Mechanism

被引:67
作者
Balakumar, Pitchai [1 ]
Arora, Mandeep Kumar
Reddy, Jayarami
Anand-Srivastava, Madhu B. [1 ]
机构
[1] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada
关键词
diabetes; nephropathy; pathophysiology; signalling mechanisms; pharmacological interventions; PROTEIN-KINASE-C; ENDOTHELIAL GROWTH-FACTOR; GLYCATION END-PRODUCTS; NITRIC-OXIDE SYNTHASE; CONVERTING-ENZYME-INHIBITION; ADP-RIBOSE POLYMERASE; HIGH-GLUCOSE; NADPH OXIDASE; ANGIOTENSIN-II; FACTOR-BETA;
D O I
10.1097/FJC.0b013e3181ad2190
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetic nephropathy is a major cause of end-stage renal failure and the mortality rate due to this disease is continuously progressing worldwide. The multifaceted signalling mechanisms have been identified to be involved in the pathogenesis of diabetic nephropathy. Despite the modern therapies like antidiabetics, anti-hypertensives, and antioxidants available to treat diabetic nephropathy; most of patients continue to show progressive renal damage. It suggests that the key pathogenic mechanism involved in the induction and progression of diabetic nephropathy is still remaining active and unmodified by the present therapies. The purpose of this review is to bring together the current information concerning the signalling systems involved in the pathogenesis of diabetic nephropathy.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 141 条
[1]   C-peptide signals via Gαi to protect against TNF-α-mediated apoptosis of opossum kidney proximal tubular cells [J].
Al-Rasheed, Nawal M. ;
Willars, Gary B. ;
Brunskill, Nigel J. .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 17 (04) :986-995
[2]   Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells [J].
Amiri, F ;
Venema, VJ ;
Wang, XD ;
Ju, H ;
Venema, RC ;
Marrero, MB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32382-32386
[3]   Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose [J].
Amiri, F ;
Shaw, S ;
Wang, XD ;
Tang, J ;
Waller, JL ;
Eaton, DC ;
Marrero, MB .
KIDNEY INTERNATIONAL, 2002, 61 (05) :1605-1616
[4]   Effects of NADPH oxidase inhibitor in diabetic nephropathy [J].
Asaba, K ;
Tojo, A ;
Onozato, ML ;
Goto, A ;
Quinn, MT ;
Fujita, T ;
Wilcox, CS .
KIDNEY INTERNATIONAL, 2005, 67 (05) :1890-1898
[5]   Nifedipine and enalapril equally reduce the progression of nephropathy in hypertensive type 2 diabetics [J].
Baba, S .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2001, 54 (03) :191-201
[6]   Possible role of poly (ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy [J].
Balakumar, P. ;
Singh, M. .
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2006, 28 (10) :683-689
[7]   Pharmacological interventions to prevent vascular endothelial dysfunction: Future directions [J].
Balakumar, Pitchai ;
Koladiya, Rajeshkumar U. ;
Ramasamy, Subbiah ;
Rathinavel, Andiappan ;
Singh, Manjeet .
JOURNAL OF HEALTH SCIENCE, 2008, 54 (01) :1-16
[8]   Differential role of Rho-kinase in pathological and physiological cardiac hypertrophy in rats [J].
Balakumar, Pitchai ;
Singh, Manjeet .
PHARMACOLOGY, 2006, 78 (02) :91-97
[9]   Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy? [J].
Balakumar, Pitchai ;
Reddy, Jayarami ;
Singh, Manjeet .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2009, 330 (1-2) :187-192
[10]   Emerging role of PPAR ligands in the management of diabetic nephropathy [J].
Balakumar, Pitchai ;
Arora, Mandeep Kumar ;
Singh, Manjeet .
PHARMACOLOGICAL RESEARCH, 2009, 60 (03) :170-173